Suppr超能文献

分子剖析 E6 PBM 鉴定出调节 Chk1 磷酸化及随后 14-3-3 识别的必需残基。

Molecular dissection of the E6 PBM identifies essential residues regulating Chk1 phosphorylation and subsequent 14-3-3 recognition.

机构信息

International Centre for Genetic Engineering and Biotechnology, Padriciano, 99-34149, Trieste, Italy.

International Centre for Genetic Engineering and Biotechnology, Padriciano, 99-34149, Trieste, Italy.

出版信息

Tumour Virus Res. 2023 Jun;15:200257. doi: 10.1016/j.tvr.2023.200257. Epub 2023 Feb 11.

Abstract

Previous studies have shown that the high-risk HPV E6 oncoprotein PDZ binding motifs (PBMs) can interact with PDZ proteins or members of the 14-3-3 family, depending upon the E6 phosphorylation status. However, different HPV E6 oncoproteins are subjected to phosphorylation by different cellular kinases. We have therefore been interested in determining whether we can dissect E6's PDZ and 14-3-3 interactions at the molecular level. Using HPV-18 E6, we have found that its Chk1 phosphorylation requires residues both upstream and downstream of the phospho-acceptor site, in addition to the Chk1 consensus recognition motif. Furthermore, we demonstrate that different high-risk HPV E6 types are differentially phosphorylated by Chk1 kinases, potentially due to the differences in their carboxy-terminal residues, as they are critical for kinase recognition. Moreover, differences in the E6 phosphorylation levels of different HR HPV types directly link to their ability to interact with different 14-3-3 isoforms, based on their phospho-status. Interestingly, 14-3-3 recognition appears to be less dependent upon the precise sequence constraints of the E6 carboxy terminal region, whilst minor amino acid variations have a major impact upon PDZ recognition. These results demonstrate that changes in E6 phospho-status during the life cycle or during malignant progression will modulate E6 interactions and, potentially, inversely regulate the levels of PDZ and 14-3-3 proteins.

摘要

先前的研究表明,高危型 HPV E6 癌蛋白 PDZ 结合基序(PBM)可以根据 E6 磷酸化状态与 PDZ 蛋白或 14-3-3 家族成员相互作用。然而,不同的 HPV E6 癌蛋白受到不同细胞激酶的磷酸化作用。因此,我们一直有兴趣确定是否可以在分子水平上剖析 E6 的 PDZ 和 14-3-3 相互作用。使用 HPV-18 E6,我们发现其 Chk1 磷酸化需要磷酸受体位点上下游的残基,除了 Chk1 共识识别基序。此外,我们证明不同的高危型 HPV E6 类型被 Chk1 激酶不同程度地磷酸化,可能是由于其羧基末端残基的差异,因为它们是激酶识别的关键。此外,不同 HR HPV 类型的 E6 磷酸化水平的差异直接与其与不同 14-3-3 同工型相互作用的能力相关,这取决于其磷酸化状态。有趣的是,14-3-3 的识别似乎不太依赖于 E6 羧基末端区域的精确序列限制,而氨基酸的微小变化对 PDZ 的识别有重大影响。这些结果表明,E6 磷酸化状态在生命周期或恶性进展过程中的变化将调节 E6 相互作用,并可能反向调节 PDZ 和 14-3-3 蛋白的水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bf0/10009279/b7fc8b96c36a/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验